Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Sims

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
International Journal of General Medicine|June 27, 2022
Prognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 PatientsLuai Madanat, Melinda Sager, Daniel O'Connor, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infectionsMatthew Sims, Valeri Mariyanovski, Patrick McLeroth, et al.
Journal of Intensive Care Medicine|February 13, 2023
A Propensity-Matched Cohort Assessing Impact of a Neutralizing Monoclonal Antibody in Mild-to-Moderate Coronavirus Disease 2019Malak Abbas, Nada Farhat, Zainab Hammoud, et al.
Frontiers in Microbiology|September 22, 2025
New diagnostic methods for <i>Escherichia marmotae</i> and the first report of its identification in clinical isolates in North AmericaPelumi M Oladipo, Robert J Tibbetts, Audun Sivertsen, et al.
Infection Control and Hospital Epidemiology|July 11, 2013
An outbreak of Pseudomonas aeruginosa respiratory tract infections associated with intrinsically contaminated ultrasound transmission gelPaul Chittick, Victoria Russo, Matthew Sims, et al.
Le Infezioni in Medicina|March 30, 2022
Evolution of prescribing practices and outcomes in the COVID-19 pandemic in metropolitan areasBenjamin Diaczok, Girish Nair, Chun-Hui Lin, et al.
BMC Infectious Diseases|November 9, 2015
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infectionTeresa L Kauf, Peggy McKinnon, G Ralph Corey, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Influenza vaccine effectiveness against hospitalized SARS-CoV-2 infectionYung-Chun Lee, Lufeiya Liu, Liyang Yuan, et al.
Epidemiology and Infection|September 3, 2025
A Retrospective Global Study of the Prevalence of O-serotypes of Invasive <i>Escherichia coli</i> Disease in Patients Admitted to Tertiary Care HospitalsJeroen Geurtsen, Joachim Doua, Luis Martinez-Martinez, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)Sahil Khanna, Matthew Sims, Thomas J Louie, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
International Journal of General Medicine|June 27, 2022
Prognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 PatientsLuai Madanat, Melinda Sager, Daniel O'Connor, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infectionsMatthew Sims, Valeri Mariyanovski, Patrick McLeroth, et al.
Journal of Intensive Care Medicine|February 13, 2023
A Propensity-Matched Cohort Assessing Impact of a Neutralizing Monoclonal Antibody in Mild-to-Moderate Coronavirus Disease 2019Malak Abbas, Nada Farhat, Zainab Hammoud, et al.
Frontiers in Microbiology|September 22, 2025
New diagnostic methods for <i>Escherichia marmotae</i> and the first report of its identification in clinical isolates in North AmericaPelumi M Oladipo, Robert J Tibbetts, Audun Sivertsen, et al.
Infection Control and Hospital Epidemiology|July 11, 2013
An outbreak of Pseudomonas aeruginosa respiratory tract infections associated with intrinsically contaminated ultrasound transmission gelPaul Chittick, Victoria Russo, Matthew Sims, et al.
Le Infezioni in Medicina|March 30, 2022
Evolution of prescribing practices and outcomes in the COVID-19 pandemic in metropolitan areasBenjamin Diaczok, Girish Nair, Chun-Hui Lin, et al.
BMC Infectious Diseases|November 9, 2015
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infectionTeresa L Kauf, Peggy McKinnon, G Ralph Corey, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Influenza vaccine effectiveness against hospitalized SARS-CoV-2 infectionYung-Chun Lee, Lufeiya Liu, Liyang Yuan, et al.
Epidemiology and Infection|September 3, 2025
A Retrospective Global Study of the Prevalence of O-serotypes of Invasive <i>Escherichia coli</i> Disease in Patients Admitted to Tertiary Care HospitalsJeroen Geurtsen, Joachim Doua, Luis Martinez-Martinez, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)Sahil Khanna, Matthew Sims, Thomas J Louie, et al.
Pageof 4